Loading...

Author: Artbits

Home / Author Archive
Labiana Juan Ortiz
Labiana strengthens its corporate governance with the appointment of Carme Hortalà and Juan Ortiz as new Board members
Artbits | 26 June

Labiana, the pharmaceutical company specializing in animal and human health listed on BME Growth, is reinforcing its corporate governance with the appointment of Carme Hortalà as a new independent director and Juan Ortiz as a new proprietary director.

Read More
Labiana incrementa su facturación en 2022 hasta los 57,85 millones de euros
Artbits | 4 May

Labiana ha hecho público su informe de resultados mostrando un incremento del 1,6% en su facturación en 2022. Apúntate al Webinar.

Read More
Privacy overview

This website uses cookies to offer you the best possible user experience. Cookies’ information is stored in your browser and performs functions such as recognizing when you return to our website or helping our team to understand which sections of the website you find most interesting and useful. More information in the privacy policy and cookie policy!